chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Information has been received from a 64 year old male patient with no known drug reaction/allergies and lymphangioma which causes him to have a large mass on his thigh.  Who on 08-NOV-2008 was vaccinated with a dose of ZOSTER (Oka/Merck).  There was no concomitant medication.  On 09-NOV-2008 the patient reported that the mass on his thigh became "very achy and he could hardly walk".  The patient also mentioned that he got the "chills".  There were no lab diagnostics studies performed.  The patient did not seek medical attention.  At the time of the report, the patient has not recovered.  No further information is available.
My daughter was very lethargic, headache, weak, could not stay up at all. Absolutely no energy. Onset was within 36 hour of vaccine. She did not get better until I start flushing her system of lemon water and detox diet food to promote flushing of metal posing and detox. Epson and ginger baths. It took a good week or two till it occurred to me that she had the shot at that it could be a correlation. That's when I began the detox.
I received my Covid-19 vaccine on 06/11/2022. On 08/29/2022 started having migraines and feeling nauseous. withing the next week I started having horrible fatigue, brain fog, ringing in ear and hyper smell. Around September 30 I was still having post Covid-19 symptoms, so I went to the doctor and tested positive for Antibodies.
The patient received the third/booster dose of BNT162b2; The patient received the third/booster dose of BNT162b2; Had sudden extreme knee pain that started 1-3 days later; Have arthritis in left knee which was diagnosed as being mild with no need for a replacement / Had sudden extreme knee pain that started 1-3 days later; This is a spontaneous report from a contactable consumer, the patient. A 74-year-old non-pregnant female patient received the third dose BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: 301458A) via an unspecified route of administration in the left arm on 05Oct2021 (at the age of 74-years-old) as a single dose for COVID-19 immunisation. Medical history included diabetic and the patient had arthritis in the left knee which was diagnosed as being mild with no need for a replacement.  It was monitored by her orthopedic doctor and the patient had received one injection in Mar2021. The patient did not have any problems since then, walking 2.5 miles a day. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included metformin (MANUFACTURER UNKNOWN), ramipril (MANUFACTURER UNKNOWN), levothyroxine sodium (SYNTHROID), amlodipine (MANUFACTURER UNKNOWN) and vitamin D nos (MANUFACTURER UNKNOWN), all taken for an unspecified indication from an unknown date and unknown if ongoing. The patient previously received the first dose BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EM9809) via an unspecified route of administration in the left arm on 06Feb2021 (at the age of 74-years-old) and also received the second dose BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6203) via an unspecified route of administration in the left arm on 27Feb2021 (at the age of 74-years-old) as a single dose for COVID-19 immunisation. On an unknown date in Oct2021, 1 to 3 days later since getting the booster, the patient had sudden extreme knee pain. The orthopedic office said that she could not get a cortisone shot to relieve the pain until 4 weeks after she received her booster shot. She was taking pain relief medications, ice packs, and rubbing it with VOLTAREN but no relief. It had been 10 days at the time of this report since her booster shot, and the patient had asked if she has to wait the full 4 weeks. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of extreme knee pain and included treatment with unspecified pain relief medications, ice packs and diclofenac (VOLTAREN). Since the vaccination, the patient had been tested for COVID-19. On 31Aug2021, the patient underwent SARS-CoV-2 test (nasal swab) and the result was negative. The clinical outcome of the event extreme knee pain was not resolved at the time of this report.
Syringe malfunction & less than 1/2 of the dose was given. Vaccine was repeated. More than 1/2 of dose squirted out the hub which was loose.  Another dose was given.
This spontaneous report was received from a physician refers to a male patient whose age was "over sixties". The patient's concurrent conditions, medical history, drug reactions, allergies and concomitant therapy were reported as unknown. On an unknown date in 2015, the patient was vaccinated with ZOSTAVAX (dose, units, frequency, lot number and expiry date unknown) for prophylaxis reported as "shingles." On an unknown date in 2017 (also reported as two years later) the patient developed acute retinal necrosis. Medical attention was sought. It was unknown if any lab diagnostics or studies performed. It was reported that the patient was treated with unknown medications and was now stable. The outcome of the event necrotizing retinitis was reported as recovered. The casual relationship between event necrotizing retinitis and ZOSTAVAX was not provided by the reporter. No product quality complaint (PQC) was reported. Upon internal review, the event necrotizing retinitis was determined to be medically significant.
Headache day 1 thru currently day 5.  Extreme tiredness from day 2 to currently. Back pain starting on day 2 and worsens by day to currently day 5.
redness; itch; hot; This case was reported by a pharmacist via call center representative and described the occurrence of injection site erythema in a 75-year-old female patient who received Herpes zoster (Shingrix) (batch number 7A7H4, expiry date 19th September 2021) for prophylaxis.   On 5th May 2019, the patient received the 1st dose of Shingrix. On 11th May 2019, 6 days after receiving Shingrix, the patient experienced injection site erythema, injection site itching and injection site warmth. On an unknown date, the outcome of the injection site erythema, injection site itching and injection site warmth were not recovered/not resolved.   It was unknown if the reporter considered the injection site erythema, injection site itching and injection site warmth to be related to Shingrix.  Additional details were provided as follows:  This case was reported by the Registered Pharmacist (RPh). The patient experienced red, itchy and hot at the injection site.  The reporter consented to follow up. There is a discrepancy in the reporting the outcome was reported in the structured field as not recovered/not resolved, but the outcome reported in the source document recovering/ resolving, however outcome is retain as per fields.
Lymph node above her collar bone swollen; Lymph node above collar bone tender; This spontaneous case was reported by a consumer and describes the occurrence of LYMPHADENOPATHY (Lymph node above her collar bone swollen) and LYMPH NODE PAIN (Lymph node above collar bone tender) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Feb-2021, the patient experienced LYMPHADENOPATHY (Lymph node above her collar bone swollen) and LYMPH NODE PAIN (Lymph node above collar bone tender). On 06-Feb-2021, LYMPH NODE PAIN (Lymph node above collar bone tender) had resolved. At the time of the report, LYMPHADENOPATHY (Lymph node above her collar bone swollen) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment information was not provided. Concomitant product use was not provided by the reporter.
Worst one was mouth ulcers for 2 to 3 months.  Made it hard to swallow.  Eventually went away.  Had fever and sweats for 2 weeks and bad muscle aches.
pt had subsequent hospitalizations starting 3/17-3/20 , 3/22, 3/23-3/25, 3/29-4/9. pt was having symptoms of bulbar dysfunction/weakness, facial weakness, HA, inability to walk. did have IVIG in hospital which did help her symptoms. drs stated rare d/t HPV but possibly guillian barre.
Redness and swelling of injection site. Progression of inflammation with use of antibiotics. Admitted for IV antibiotics (Zosyn).
On Sunday night, I noticed that I had a scratchy throat. On Monday as well. Tuesday, I had a low grade fever and chills. On Wednesday my temp was gone but I had a body aches runny nose and coughing. On Thursday, I tested positive. I am still dealing with body aches, coughing and runny nose. I am still positive 6 days later.
PATIENT COMPLAINED OF WAVE OF NAUSEA.  LAYED ON COT AND OBSERVED
Left arm has been sore/ soreness that runs from my shoulder all the way to my hand; Soreness that runs from my shoulder all the way to my hand; Burning inside my upper left arm to my shoulder and chest; Burning inside my upper left arm to my shoulder and chest; This is a spontaneous report from a contactable healthcare professional reporting for herself. A 24-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE) (lot number/expiration date: not provided), via intramuscular route of administration, on 11Jan2021 (at the age of 24 years old) as a single dose in the left arm for COVID-19 IMMUNIZATION. Relevant medical history was none. The patient previously received the first dose of BNT162B2 (lot number/expiration date: not provided) on 23Dec2020 (at the age of 24 years old) at 07:45 PM via intramuscular route of administration as a single dose in the left arm for COVID-19 IMMUNIZATION. The patient did not have any known allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medication (other medications taken in two weeks) were none. The patient was not pregnant at the time of vaccination. The patient did not receive any other vaccines within 4 weeks (other than the first dose of BNT162B2) prior to the COVID vaccine. On 18Jan2021 at 07:30, the patient experienced left arm has been sore. The patient described it as "my left arm had been sore this past week of 18Jan2021, it is a soreness that runs from my shoulder all the way to my hand, then goes up again and concentrates from my upper left arm it starts burning inside my upper left arm to my shoulder and chest and stays the burning for a few seconds to a minute". The events were reported as non-serious. The patient did not receive any treatment for these events. The outcome of the events left arm sore, shoulder sore, and burning inside upper left arm to shoulder and chest was unknown. Since the vaccination, the patient had not been tested for COVID-19.  The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow-up.
Patient reported 2/10 chest pressure 5 minutes after receiving the Moderna booster. Patient was escorted to the nurse clinic where vital signs were taken. Chest pressure decreased to 1/10 with a few minutes of rest. Patient declined to be evaluated by a doctor and wanted to leave.
60 hours after the second injection hives began to appear on hands starting on the thumbs and pointer fingers of both hands.  6 hours later hives spread to cover the whole hands and started above the beltline on the small of the back.  4 hours later hives had spread up the back reaching around the ribs to the chest in lines.  6 hours later the rash was starting on the head, forearms, feet, shins, neck, chest, shoulders, and hands were swollen and painful to open and close. 88 hours after the injection medical attention was sought, the PA recommended use of Benadryl Over the counter capsules taken 1X per day before bed and Claritin capsules taken 1X per day in the morning.  as of 6 days after the second vaccine the hives have stopped spreading and the swelling in the hands and feet has gone down. Hives are still present but not as inflamed.
Pt called back to pharmacy 8 hours later complaining about severe ball shoulder pain. It was in left arm that I administered the PNEUMOVAX shot.
pt recvd vax MAR92 & JUN93 parents learned pt had memory impairment or a learning disability; pt was scheduled for eval;
My sister traveled to stay with me on the week of September 20th 2021, she felt ill on September 22 2021 with a very bad cough and fever. I felt ill the next day, on the 23rd. On the 25th we both got tested for COVID-19. We were both negative. She was very ill, but I was coughing and had a low grade fever at that time. Knowing I did not have COVID-19, I was just treating myself for an upper respiratory infection. I was home sick for that time. I was coughing, having trouble breathing and sharpness in my chest like knives. I took Tylenol every four hours and drinking Pedialyte and also taking Mucinex. For the first week, my chest was really bad so I was making myself walk around and take deep breathes because I was fearful that it would turn into Pneumonia. The fever broke around October 3rd. I was weak and didn't feel good still but was getting a little better. On October 5th my friend called the ambulance because I was coughing and my back went out. I was in extraordinary pain so the ambulance took me to the hospital. When I got there, they tested me for COVID-19 and Flu, both negative. They did testing and some of my testing came back normal, without a copy of the test I cannot tell you what all that was. I had some sort of strain on my heart and was admitted to the hospital on the 5th of October and they did full test for upper respiratory infections and I tested positive for an infection. I was discharged on the 6th and followed up with my heart Dr. I saw her on the 11th or 12th of October. She sent me home and told me to continue to taking Tylenol. Today I have a follow up with my GP and he may advise other follow up treatment. Also around October 7th my left ear plugged and I got a really bad earache, I used over the counter ear drops for that as well. When I did see the Cardiologist she noticed my left side lymph nodes were very swollen and they still are today as well.
I felt tired and sickly for about 24 hours after receiving the vaccine. I had a headache, feverish, feeling ill and tired when I tested positive for COVID-19 in 08/2022. I contacted my doctor and got a prescription for Paxlovid. I tolerated the medication, but it left a terrible taste in mouth. As of today, I do not have any lingering symptoms.
BLURRY VISION; JOINT ISSUES; SORE THROAT; BREAKING OUT IN COLD SWEAT (MOSTLY HER HEAD); CHILLS; LOW GRADE FEVER; FEET HURT; SHORTNESS OF BREATH; HIGH HEART RATE; FELT LIKE GOING TO FAINT; MUSCLE ACHE; BAD HEADACHE; VOMITING; This spontaneous report received from a patient concerned a 68 year old female. The patient's weight was not reported and height was 67 inches. The patient's past medical history included: flu, and concurrent conditions included: hashimoto's disease, sjogren's disease, non-alcohol user, and non-smoker, and other pre-existing medical conditions included: The patient had no known drug allergies. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on MAR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On MAR-2021, the patient experienced vomiting. On MAR-2021, the patient experienced muscle ache. On MAR-2021, the patient experienced bad headache. On 17-AUG-2021, the patient experienced shortness of breath. On 17-AUG-2021, the patient experienced high heart rate. On 17-AUG-2021, the patient experienced felt like going to faint. Laboratory data included: Heart rate (NR: not provided) 117 {beats}/min, 83 {beats}/min, leveled off. On an unspecified date, the patient experienced blurry vision, joint issues, sore throat, breaking out in cold sweat (mostly her head), chills, low grade fever, and feet hurt. Laboratory data (dates unspecified) included: Antibody test (NR: not provided) 180, Titer 640, Blood test (NR: not provided) Something was low but not sure what it was, COVID-19 virus test (NR: not provided) Negative, Negative, and Hepatic enzyme (NR: not provided) Have been different. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from high heart rate on 17-AUG-2021, and vomiting, had not recovered from bad headache, muscle ache, joint issues, breaking out in cold sweat (mostly her head), and feet hurt, and the outcome of blurry vision, chills, sore throat, low grade fever, shortness of breath and felt like going to faint was not reported. This report was non-serious.
No adverse event occurred.  Reporting medication error: wrong dose for patient age.  Details: Patient identifier verified by name and date of birth, however patient age was not established verbally neither by patient, parent or nurse.  Clinic is set up only for 5-11 year old patient population, parent booked appointment by calling central appointment number.   Parent was notified of medication error and advised to complete the vaccination series with appropriate dose for age-group in 21days. Processes will be established to ensure error does not occur again.
I woke up that morning with severe lower back pain and a severe burning sensation on the top of my left leg. Lower back and both hips were in throbbing pain. I went to a chiropractor 3 times a week where I was advised to take multiple different types of vitamins and to use constant ice pack. I had a spine, hip, and knee x-rays with no indications. I went to a spine surgeon which wanted to give me a prescription of pain medicines which I refused to take.  During this time, I could only sleep on my side and could not lay on my back at all. This affected my sleep cycle. This lasted for 4 weeks and eventually subsided. I have had some issues recently where this issue has acted up again.
This spontaneous report as received from a pharmacist refers to a patient of unknown age and gender. No concurrent condition, medical history or allergy/drug reactions were reported. On 175-DEC-2015 at 09:44, the patient was vaccinated with improperly stored RECOMBIVAX HB with lot number: L025738, expiry date: unspecified (dose and strength unspecified). No concomitant medications were reported. No adverse effects were reported. The high and low temperatures were 7.6 and 5.1 (units unspecified) respectively. There were no product quality complaints (PQC) involved. No additional information was provided. This is one of the several reports from the same reporter. Additional information has been requested.
PATIENT PRESENTED TO THE ER WITH COORDINATION ISSUES.  THEY WERE UNABLE TO DETERMINE A CAUSE , BUT THEIR BEST GUESS WAS SEIZURE RELATED. PATIENT WAS RELEASED THAT DAY.
No adverse effects reported; a dose of PROQUAD which expired on 8/8/2020; This spontaneous report was received from a nurse practitioner regarding a patient of unknown age and gender. The patient's pertinent medical history, concomitant medications and drug reactions/allergies were not provided.  On 12-AUG-2020, a dose of expired measles, mumps, rubella and varicella (Oka-Merck) virus vaccine live, recombinant human albumin (rHA) (PROQUAD) (lot S003864 and expiration date: 08-AUG-2020; strength, route, anatomical location were not reported) was administered to the patient for prophylaxis (expired product administered). This was supported as per stability memo. The outcome was not provided. No adverse effects were reported.
7/16/21 - POLYNEUROPATHY -  7/18/21 - HYPOXIA -
Patient called on 4/5/11 wanted to know how long headache last. He got shot on 3/30/11. He had HA for 5 days, also itching & numbness of upper lip. Told patient to check with his MD, to make sure nothing else was going on. I told him I would contact Merck & Co to get more info. Merck called back they reported those symptoms in first trial & post marketing trail. No #'s.
chest pain; metallic taste in his mouth "that comes and goes."; felt fatigue/exhaustion; weakness; This is a spontaneous report from a contactable consumer from Pfizer sponsored program (patient himself). A 36-years-old male patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection; Batch/Lot number, Expiry date, NDC number, UPC number was not reported), via an unspecified route of administration on 03Sep2021 as dose 1, single for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. Caller's mother was on the phone and she transferred the phone to her son (36 y/o male). He received his first Comirnaty vaccine on 03Sep2021. He immediately experienced a metallic taste in his mouth that comes and goes. He experienced chest pain on 07Sep2021 and had felt fatigue, weakness, and exhaustion since receiving the vaccine and that was still continuing. Caller seeking information on these side effects. The outcome of events metallic taste in his mouth that comes and goes, chest pain was unknown, and rest of the events was not recovered.  The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.
4:30pm- vaccine given. 4:40pm- client reported having a 'weird sensation' in the back of his throat to EMT. 4:45pm- 25mg PO benadryl given. In stable condition. Declined SOB, itching, hives. No angioedema noted. 5:00pm- client states no worsening or improvement of 'weird sensation' to the back of his throat. Another 25 PO benadryl given. 5:15pm- client reports all symptoms resolved. Monitored and left at 5:25pm.  Declined any further medical care during time in public health vaccine clinic.
pain and redness at site of injection , red rash all over body, urgent facility prescribed steroids Moderna Covid-19 Vaccine EUA
Patient received Pfizer COVID vaccine on 2/26/21 (lot # EN6198), 3/26/21 (lot # EP6955), and 12/14/21 (lot # FE3594). On 10/10/22, patient admitted to our inpatient med/surg unit with generalized severe weakness, asymptomatic bacteruria, and diarrhea (all secondary to COVID19 infection). Patient was discharged home on 10/12/22.
Patient has not had any adverse event to report, Patient received a pedi pfizer 2nd dose which was not diluted. Dose given was 0.2ml, however the concentration of the dose was higher than required. I contacted CDC, and Pfizer reps to report incident.  I also called child's parent to explain error and inform them of the info received from CDC and Pfizer reps.  Parent was understanding and will monitor child for any adverse events.